お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962222

糖鎖生物学の世界市場:新薬開発向け糖鎖生物学酵素の応用の増加が需要を促進

Global Market Study on Glycobiology: Rising Application of Glycobiology Enzymes for Novel Drug Development to Boost Demand

出版日: | 発行: Persistence Market Research | ページ情報: 英文 300 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.61円
糖鎖生物学の世界市場:新薬開発向け糖鎖生物学酵素の応用の増加が需要を促進
出版日: 2020年08月20日
発行: Persistence Market Research
ページ情報: 英文 300 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の糖鎖生物学市場について調査分析し、市場力学、市場構造、市場分析と予測、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場カバレッジ/分類法
  • 市場の定義/範囲/制限事項
  • 包含と除外

第3章 主な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 主要成功要因

  • 糖鎖生物学の採用率/使用率分析:主要統計
  • 主要プロモーション戦略:主要メーカー別
  • 主要規制:地域別

第5章 市場の背景

  • マクロ経済的要因
  • 予測要因:関連性と影響
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析
  • COVID-19危機分析

第6章 世界の糖鎖生物学市場の需要分析と予測

  • 過去の市場分析
  • 現在・将来の市場予測
  • 前年比成長動向分析

第7章 世界の糖鎖生物学市場の価格分析

  • 地域の価格分析:製品別
  • 価格の内訳
    • メーカーレベルの価格
    • ディストリビューターレベルの価格
  • 世界の平均価格分析ベンチマーク

第8章 世界の糖鎖生物学市場分析と予測

  • 過去の市場分析
  • 現在・将来の市場予測
    • 前年比成長動向分析

第9章 世界の糖鎖生物学市場分析と予測:製品別

  • イントロダクション/主な調査結果
  • 過去の市場:製品別
  • 現在・将来の市場分析と予測:製品別
    • 計器
    • 酵素
    • 消耗品
    • 試薬キット
  • 市場の魅力分析:製品別

第10章 世界の糖鎖生物学市場分析と予測:酵素別

  • イントロダクション/主な調査結果
  • 過去の市場:酵素別
  • 現在・将来の市場分析と予測:酵素別
    • ガラクトシダーゼ
    • GlcNAc転移酵素
    • フコシル転移酵素
    • GalNAc転移酵素
    • ガラクトシル転移酵素
    • グルクロノシル転移酵素
    • グルコシル転移酵素
    • ペントシル転移酵素
    • 炭水化物キナーゼ
    • ノイラミニダーゼ
    • シアリル転移酵素
    • その他
  • 市場の魅力分析:酵素別

第11章 世界の糖鎖生物学市場分析と予測:応用別

  • イントロダクション/主な調査結果
  • 過去の市場:応用別
  • 現在・将来の市場と予測:応用別
  • 市場の魅力分析:応用別

第12章 世界の糖鎖生物学市場分析と予測:エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場分析:エンドユーザー別
  • 現在・将来の市場分析と予測:エンドユーザー別
  • 市場の魅力分析:エンドユーザー別

第13章 世界の糖鎖生物学市場分析と予測:地域別

  • イントロダクション
  • 過去の市場分析:地域別
  • 現在の市場分析と予測:地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場の魅力分析:地域別

第14章 北米の糖鎖生物学市場分析と予測

第15章 ラテンアメリカの糖鎖生物学市場分析と予測

第16章 欧州の糖鎖生物学市場分析と予測

第17章 南アジアの糖鎖生物学市場分析と予測

第18章 東アジアの糖鎖生物学市場分析と予測

第19章 オセアニアの糖鎖生物学市場分析と予測

第20章 中東・アフリカの糖鎖生物学市場分析と予測

第21章 主要国・新興国の糖鎖生物学市場分析と予測

第22章 市場構造分析

第23章 競合分析

  • 競合ダッシュボード
  • 価格分析:競合別
  • 競合ベンチマーキング
  • 競合分析
    • Merck KGaA
    • Bio-Techne Corporation
    • Bruker Corporation
    • Thermo Fisher Scientific, Inc.
    • Shimadzu Corporation
    • ProZyme Inc.
    • NEB Inc.
    • Agilent Technologies
    • New England Biolabs
    • Takara Bio
    • Waters Corporation
    • Danaher Corporation

第24章 前提条件と略語

第25章 調査手法

図表

List of Tables

  • Table 01: Global Glycobiology Market Volume ('000 Units) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 02: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 03: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 04: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 05: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 06: Global Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Region
  • Table 07: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 08: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 09: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 10: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 11: North America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 12: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 13: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 14: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 15: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 16: Latin America Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 17: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 18: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 19: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 20: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 21: Europe Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 22: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 23: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 24: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 25: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 26: South Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 27: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 28: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 29: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 30: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 31: East Asia Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 32: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 33: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 34: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 35: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 36: Oceania Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User
  • Table 37: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Country
  • Table 38: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Product
  • Table 39: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Enzyme
  • Table 40: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By Application
  • Table 41: MEA Glycobiology Market Value (US$ Mn) Analysis and Opportunity Assessment 2015-2030, By End User

List of Figures

  • Figure 01: Global Glycobiology Market Volume (Mn Units) Analysis, 2015-2019
  • Figure 02: Global Glycobiology Market Volume Forecast (Mn Units), 2020-2030
  • Figure 03: Global Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 04: Global Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 05: Global Glycobiology Market Absolute $ Opportunity, 2020 - 2030
  • Figure 06: Global Glycobiology Market Share Analysis (%), By Product, 2020-2030
  • Figure 07: Global Glycobiology Market Y-o-Y Analysis (%), By Product, 2020-2030
  • Figure 08: Global Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 09: Global Glycobiology Market Share Analysis (%), By Enzyme, 2020-2030
  • Figure 10: Global Glycobiology Market Y-o-Y Analysis (%), By Enzyme, 2020-2030
  • Figure 11: Global Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 12: Global Glycobiology Market Share Analysis (%), By Application, 2020-2030
  • Figure 13: Global Glycobiology Market Y-o-Y Analysis (%), By Application, 2020-2030
  • Figure 14: Global Glycobiology Market Attractiveness Analysis by Size, 2020-2030
  • Figure 15: Global Glycobiology Market Share Analysis (%), By End User, 2020-2030
  • Figure 16: Global Glycobiology Market Y-o-Y Analysis (%), By End User, 2020-2030
  • Figure 17: Global Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 18: Global Glycobiology Market Share Analysis (%), By Region, 2020-2030
  • Figure 19: Global Glycobiology Market Y-o-Y Analysis (%), By Region, 2020-2030
  • Figure 20: Global Glycobiology Market Attractiveness Analysis by Region, 2020-2030
  • Figure 21: North America Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 22: North America Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 23: North America Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 24: North America Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 25: North America Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 26: North America Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 27: North America Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 28: North America Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 29: North America Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 30: North America Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 31: North America Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 32: North America Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 33: Latin America Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 34: Latin America Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 35: Latin America Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 36: Latin America Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 37: Latin America Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 38: Latin America Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 39: Latin America Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 40: Latin America Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 41: Latin America Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 42: Latin America Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 43: Latin America Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 44: Latin America Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 45: Europe Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 46: Europe Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 47: Europe Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 48: Europe Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 49: Europe Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 50: Europe Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 51: Europe Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 52: Europe Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 53: Europe Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 54: Europe Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 55: Europe Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 56: Europe Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 57: South Asia Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 58: South Asia Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 59: South Asia Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 60: South Asia Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 61: South Asia Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 62: South Asia Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 63: South Asia Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 64: South Asia Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 65: South Asia Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 66: South Asia Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 67: South Asia Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 68: South Asia Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 69: East Asia Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 70: East Asia Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 71: East Asia Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 72: East Asia Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 73: East Asia Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 74: East Asia Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 75: East Asia Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 76: East Asia Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 77: East Asia Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 78: East Asia Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 79: East Asia Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 80: East Asia Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 81: Oceania Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 82: Oceania Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 83: Oceania Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 84: Oceania Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 85: Oceania Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 86: Oceania Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 87: Oceania Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 88: Oceania Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 89: Oceania Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 90: Oceania Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 91: Oceania Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 92: Oceania Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 93: MEA Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 94: MEA Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 95: MEA Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 96: MEA Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 97: MEA Glycobiology Market Value Share, By Country, 2020 (E)
  • Figure 98: MEA Glycobiology Market Value Analysis (US$ Mn), 2015-2019
  • Figure 99: MEA Glycobiology Market Value Forecast (US$ Mn), 2020-2030
  • Figure 100: MEA Glycobiology Market Attractiveness Analysis By Product, 2020-2030
  • Figure 101: MEA Glycobiology Market Attractiveness Analysis by Enzyme, 2020-2030
  • Figure 102: MEA Glycobiology Market Attractiveness Analysis by Application, 2020-2030
  • Figure 103: MEA Glycobiology Market Attractiveness Analysis by End User, 2020-2030
  • Figure 104: MEA Glycobiology Market Attractiveness Analysis by Country, 2020-2030
  • Figure 105: U. S. Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 106: U. S. Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 107: U. S. Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 108: U. S. Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 109: U. S. Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 110: Canada Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 111: Canada Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 112: Canada Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 113: Canada Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 114: Canada Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 115: Brazil Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 116: Brazil Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 117: Brazil Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 118: Brazil Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 119: Brazil Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 120: Mexico Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 121: Mexico Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 122: Mexico Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 123: Mexico Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 124: Mexico Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 125: U. K. Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 126: U. K. Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 127: U. K. Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 128: U. K. Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 129: U. K. Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 130: Germany Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 131: Germany Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 132: Germany Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 133: Germany Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 134: Germany Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 135: France Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 136: France Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 137: France Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 138: France Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 139: France Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 140: Italy Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 141: Italy Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 142: Italy Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 143: Italy Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 144: Italy Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 145: Spain Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 146: Spain Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 147: Spain Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 148: Spain Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 149: Spain Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 150: Russia Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 151: Russia Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 152: Russia Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 153: Russia Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 154: Russia Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 155: China Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 156: China Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 157: China Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 158: China Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 159: China Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 160: Japan Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 161: Japan Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 162: Japan Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 163: Japan Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 164: Japan Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 165: South Korea Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 166: South Korea Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 167: South Korea Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 168: South Korea Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 169: South Korea Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 170: India Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 171: India Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 172: India Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 173: India Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 174: India Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 175: Indonesia Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 176: Indonesia Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 177: Indonesia Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 178: Indonesia Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 179: Indonesia Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 180: Australia Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 181: Australia Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 182: Australia Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 183: Australia Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 184: Australia Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 185: New Zealand Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 186: New Zealand Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 187: New Zealand Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 188: New Zealand Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 189: New Zealand Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 190: GCC Countries Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 191: GCC Countries Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 192: GCC Countries Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 193: GCC Countries Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 194: GCC Countries Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 195: Turkey Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 196: Turkey Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 197: Turkey Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 198: Turkey Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 199: Turkey Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
  • Figure 200: South Africa Glycobiology Market Value Share, By Product, 2020 (E)
  • Figure 201: South Africa Glycobiology Market Value Share, By Enzyme, 2020 (E)
  • Figure 202: South Africa Glycobiology Market Value Share, By Application, 2020 (E)
  • Figure 203: South Africa Glycobiology Market Value Share, By End User, 2020 (E)
  • Figure 204: South Africa Glycobiology Market Value Analysis (US$ Mn), 2020 & 2030
目次

Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global glycobiology market. The study provides detailed assessment of key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the glycobiology market structure. The market study presents exclusive information about how the glycobiology market will grow during the forecast period (2020-2030).

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compound annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. Other information includes definitions, drivers, and opportunity analysis by region and by product, which helps in the deep understanding of the market segment details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the glycobiology market during the forecast period.

The study is relevant for manufacturers, physicians, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researchers, shareholders, and industry experts can leverage the information and data presented in PMR's study.

The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the glycobiology market. Furthermore, small businesses and new entrants in the glycobiology market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

PMR's study on the glycobiology market offers information divided into five important segments-product, enzyme, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for glycobiology market players?
  • Which factors will induce a change in the demand for glycobiology during the assessment period?
  • What are the different opportunities available for emerging players in the glycobiology market?
  • How are supply-side and demand-side drivers impacting the glycobiology market?
  • How will changing trends impact the glycobiology market?
  • How can market players capture the low-hanging opportunities in the glycobiology market in developed regions?
  • Which companies are leading the glycobiology market?
  • What are the winning strategies of stakeholders in the glycobiology market to upscale their position in this landscape?

Research Methodology:

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the glycobiology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the glycobiology market study include statistics from government healthcare organizations, medicines journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the glycobiology market, and makes PMR's projections on the growth prospects of the glycobiology market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Glycobiology Adoption Rate/Usage Analysis- Key Statistics
  • 4.2. Key Promotional Strategies, By Key Manufacturers
  • 4.3. Key Regulations, By Region

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Market Outlook
    • 5.1.3. Global Life Science Market Outlook
    • 5.1.4. Global Cancer Diagnostic Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Key Players Historical Growth
    • 5.2.2. Market Consolidation Activities
    • 5.2.3. Availability of Glycobiology Across Regions
    • 5.2.4. Cost of Product & Services
    • 5.2.5. Product Adoption
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis
  • 5.4. COVID19 Crisis Analysis
    • 5.4.1. Current COVID19 Statistics and Probable Future Impact
    • 5.4.2. Current GDP Projection and Probable Impact
    • 5.4.3. Current Economic Projection as compared to 2008 financial analysis
    • 5.4.4. COVID19 and Impact Analysis
      • 5.4.4.1. Revenue By Product
      • 5.4.4.2. Revenue By Enzyme Type
      • 5.4.4.3. Revenue By Application
      • 5.4.4.4. Revenue By Country
    • 5.4.5. 2020 Market Scenario
    • 5.4.6. Quarter by Quarter Forecast
    • 5.4.7. Projected recovery Quarter
    • 5.4.8. Recovery Scenario - Short term, Midterm and Long Term Impact

6. Global Glycobiology Market Demand (in Volume units) Analysis 2015-2019 and Forecast, 2020-2030

  • 6.1. Historical Market Volume (Units) Analysis, 2015-2020
  • 6.2. Current and Future Market Volume (Units) Projections, 2020-2030
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Glycobiology Market Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark

8. Global Glycobiology Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 8.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) By Product, 2015-2019
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2020-2030
    • 9.3.1. Instruments
    • 9.3.2. Enzymes
    • 9.3.3. Consumables
    • 9.3.4. Reagent Kits
  • 9.4. Market Attractiveness Analysis by Product

10. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Enzyme

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) By Enzyme, 2015-2019
  • 10.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Enzyme, 2020-2030
    • 10.3.1. Galactosidases
      • 10.3.1.1. Fucosidases
      • 10.3.1.2. Chitinases
      • 10.3.1.3. Acetylgalactosaminidase
      • 10.3.1.4. Heparinase
      • 10.3.1.5. PNGase F
      • 10.3.1.6. Others
    • 10.3.2. GlcNAc Transferases
      • 10.3.2.1. Acetylglucosaminyl transferase
      • 10.3.2.2. Exostosin
      • 10.3.2.3. Others
    • 10.3.3. Fucosyltransferases
    • 10.3.4. GalNAc Transferases
    • 10.3.5. Galactosyl Transferases
    • 10.3.6. Glucuronosyltransferases
    • 10.3.7. Glucosyltransferases
    • 10.3.8. Pentosyltransferases
    • 10.3.9. Carbohydrate Kinases
    • 10.3.10. Neuraminidases
    • 10.3.11. Sialyltransferases
    • 10.3.12. Others
  • 10.4. Market Attractiveness Analysis By Enzyme

11. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and By Application, 2015-2019
  • 11.3. Current and Future Market Size (US$ Mn) and Forecast By Application, 2020-2030
      • 11.3.1.1. Drug Discovery and Development
      • 11.3.1.2. Diagnostic Applications
        • 11.3.1.2.1. Oncology
        • 11.3.1.2.2. Immunology
        • 11.3.1.2.3. Others
      • 11.3.1.3. Industrial Application
      • 11.3.1.4. Therapeutic Application
        • 11.3.1.4.1. Oncology
        • 11.3.1.4.2. Immunology
        • 11.3.1.4.3. Others
      • 11.3.1.5. Others
  • 11.4. Market Attractiveness Analysis by Application

12. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
      • 12.3.1.1. Biopharmaceutical Companies
      • 12.3.1.2. Research Laboratories
      • 12.3.1.3. Hospitals
      • 12.3.1.4. Diagnostic Centers
      • 12.3.1.5. Contract Research Organizations
      • 12.3.1.6. Biotechnology Industries
      • 12.3.1.7. Academic Institutes
      • 12.3.1.8. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Enzyme
    • 14.3.4. By Application
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis

15. Latin America Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Enzyme
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis

16. Europe Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Enzyme
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis

17. South Asia Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Enzyme
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis

18. East Asia Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Enzyme
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis

19. Oceania Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Enzyme
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
  • 20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Enzyme
    • 20.3.4. By Application
    • 20.3.5. By End User
  • 20.4. Market Attractiveness Analysis
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Glycobiology Market Analysis 2015-2019 and Forecast 2020-2030

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis, By Key Countries
    • 21.1.2. Global Vs. Country Growth Comparison
  • 21.2. U.S. Glycobiology Market Analysis
    • 21.2.1. By Product
    • 21.2.2. By Enzyme
    • 21.2.3. By Application
    • 21.2.4. By End User
  • 21.3. Canada Glycobiology Market Analysis
    • 21.3.1. By Product
    • 21.3.2. By Enzyme
    • 21.3.3. By Application
    • 21.3.4. By End User
  • 21.4. Mexico Glycobiology Market Analysis
    • 21.4.1. By Product
    • 21.4.2. By Enzyme
    • 21.4.3. By Application
    • 21.4.4. By End User
  • 21.5. Brazil Glycobiology Market Analysis
    • 21.5.1. By Product
    • 21.5.2. By Enzyme
    • 21.5.3. By Application
    • 21.5.4. By End User
  • 21.6. U.K. Glycobiology Market Analysis
    • 21.6.1. By Product
    • 21.6.2. By Enzyme
    • 21.6.3. By Application
    • 21.6.4. By End User
  • 21.7. Germany Glycobiology Market Analysis
    • 21.7.1. By Product
    • 21.7.2. By Enzyme
    • 21.7.3. By Application
    • 21.7.4. By End User
  • 21.8. France Glycobiology Market Analysis
    • 21.8.1. By Product
    • 21.8.2. By Enzyme
    • 21.8.3. By Application
    • 21.8.4. By End User
  • 21.9. Italy Glycobiology Market Analysis
    • 21.9.1. By Product
    • 21.9.2. By Enzyme
    • 21.9.3. By Application
    • 21.9.4. By End User
  • 21.10. Spain Glycobiology Market Analysis
    • 21.10.1. By Product
    • 21.10.2. By Enzyme
    • 21.10.3. By Application
    • 21.10.4. By End User
  • 21.11. BENELUX Glycobiology Market Analysis
    • 21.11.1. By Product
    • 21.11.2. By Enzyme
    • 21.11.3. By Application
    • 21.11.4. By End User
  • 21.12. Russia Glycobiology Market Analysis
    • 21.12.1. By Product
    • 21.12.2. By Enzyme
    • 21.12.3. By Age Group
    • 21.12.4. By End User
  • 21.13. China Glycobiology Market Analysis
    • 21.13.1. By Product
    • 21.13.2. By Enzyme
    • 21.13.3. By Application
    • 21.13.4. By End User
  • 21.14. Japan Glycobiology Market Analysis
    • 21.14.1. By Product
    • 21.14.2. By Enzyme
    • 21.14.3. By Application
    • 21.14.4. By End User
  • 21.15. South Korea Glycobiology Market Analysis
    • 21.15.1. By Product
    • 21.15.2. By Enzyme
    • 21.15.3. By Application
    • 21.15.4. By End User
  • 21.16. India Glycobiology Market Analysis
    • 21.16.1. By Product
    • 21.16.2. By Enzyme
    • 21.16.3. By Application
    • 21.16.4. By End User
  • 21.17. ASEAN Glycobiology Market Analysis
    • 21.17.1. By Product
    • 21.17.2. By Enzyme
    • 21.17.3. By Application
    • 21.17.4. By End User
  • 21.18. Australia Glycobiology Market Analysis
    • 21.18.1. By Product
    • 21.18.2. By Enzyme
    • 21.18.3. By Application
    • 21.18.4. By End User
  • 21.19. New Zealand Glycobiology Market Analysis
    • 21.19.1. By Product
    • 21.19.2. By Enzyme
    • 21.19.3. By Application
    • 21.19.4. By End User
  • 21.20. GCC Countries Glycobiology Market Analysis
    • 21.20.1. By Product
    • 21.20.2. By Enzyme
    • 21.20.3. By Application
    • 21.20.4. By End User
  • 21.21. Turkey Glycobiology Market Analysis
    • 21.21.1. By Product
    • 21.21.2. By Enzyme
    • 21.21.3. By Application
    • 21.21.4. By End User
  • 21.22. South Africa Glycobiology Market Analysis
    • 21.22.1. By Product
    • 21.22.2. By Enzyme
    • 21.22.3. By Application
    • 21.22.4. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Concentration
  • 22.3. Market Share Analysis of Top Players
  • 22.4. Market Presence Analysis
      • 22.4.1.1. Regional footprint of Players
      • 22.4.1.2. Product foot print by Players
      • 22.4.1.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Pricing Analysis by Competition
  • 23.3. Competition Benchmarking
  • 23.4. Competition Deep Dive
    • 23.4.1. Merck KGaA
      • 23.4.1.1. Overview
      • 23.4.1.2. Product Portfolio
      • 23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.1.4. Sales Footprint
      • 23.4.1.5. Analyst Commentary
      • 23.4.1.6. Strategy Overview
        • 23.4.1.6.1. Marketing Strategy
        • 23.4.1.6.2. Product Strategy
        • 23.4.1.6.3. Channel Strategy
    • 23.4.2. Bio-Techne Corporation
      • 23.4.2.1. Overview
      • 23.4.2.2. Product Portfolio
      • 23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.2.4. Sales Footprint
      • 23.4.2.5. Analyst Commentary
      • 23.4.2.6. Strategy Overview
        • 23.4.2.6.1. Marketing Strategy
        • 23.4.2.6.2. Product Strategy
        • 23.4.2.6.3. Channel Strategy
    • 23.4.3. Bruker Corporation
      • 23.4.3.1. Overview
      • 23.4.3.2. Product Portfolio
      • 23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.3.4. Sales Footprint
      • 23.4.3.5. Analyst Commentary
      • 23.4.3.6. Strategy Overview
        • 23.4.3.6.1. Marketing Strategy
        • 23.4.3.6.2. Product Strategy
        • 23.4.3.6.3. Channel Strategy
    • 23.4.4. Thermo Fisher Scientific, Inc.
      • 23.4.4.1. Overview
      • 23.4.4.2. Product Portfolio
      • 23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.4.4. Sales Footprint
      • 23.4.4.5. Analyst Commentary
      • 23.4.4.6. Strategy Overview
        • 23.4.4.6.1. Marketing Strategy
        • 23.4.4.6.2. Product Strategy
        • 23.4.4.6.3. Channel Strategy
    • 23.4.5. Shimadzu Corporation
      • 23.4.5.1. Overview
      • 23.4.5.2. Product Portfolio
      • 23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.5.4. Sales Footprint
      • 23.4.5.5. Analyst Commentary
      • 23.4.5.6. Strategy Overview
        • 23.4.5.6.1. Marketing Strategy
        • 23.4.5.6.2. Product Strategy
        • 23.4.5.6.3. Channel Strategy
    • 23.4.6. ProZyme Inc.
      • 23.4.6.1. Overview
      • 23.4.6.2. Product Portfolio
      • 23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.6.4. Sales Footprint
      • 23.4.6.5. Analyst Commentary
      • 23.4.6.6. Strategy Overview
        • 23.4.6.6.1. Marketing Strategy
        • 23.4.6.6.2. Product Strategy
        • 23.4.6.6.3. Channel Strategy
    • 23.4.7. NEB Inc.
      • 23.4.7.1. Overview
      • 23.4.7.2. Product Portfolio
      • 23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.7.4. Sales Footprint
      • 23.4.7.5. Analyst Commentary
      • 23.4.7.6. Strategy Overview
        • 23.4.7.6.1. Marketing Strategy
        • 23.4.7.6.2. Product Strategy
        • 23.4.7.6.3. Channel Strategy
    • 23.4.8. Agilent Technologies
      • 23.4.8.1. Overview
      • 23.4.8.2. Product Portfolio
      • 23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.8.4. Sales Footprint
      • 23.4.8.5. Analyst Commentary
      • 23.4.8.6. Strategy Overview
        • 23.4.8.6.1. Marketing Strategy
        • 23.4.8.6.2. Product Strategy
        • 23.4.8.6.3. Channel Strategy
    • 23.4.9. New England Biolabs
      • 23.4.9.1. Overview
      • 23.4.9.2. Product Portfolio
      • 23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.9.4. Sales Footprint
      • 23.4.9.5. Analyst Commentary
      • 23.4.9.6. Strategy Overview
        • 23.4.9.6.1. Marketing Strategy
        • 23.4.9.6.2. Product Strategy
        • 23.4.9.6.3. Channel Strategy
    • 23.4.10. Takara Bio
      • 23.4.10.1. Overview
      • 23.4.10.2. Product Portfolio
      • 23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.10.4. Sales Footprint
      • 23.4.10.5. Analyst Commentary
      • 23.4.10.6. Strategy Overview
        • 23.4.10.6.1. Marketing Strategy
        • 23.4.10.6.2. Product Strategy
        • 23.4.10.6.3. Channel Strategy
    • 23.4.11. Waters Corporation
      • 23.4.11.1. Overview
      • 23.4.11.2. Product Portfolio
      • 23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.11.4. Sales Footprint
      • 23.4.11.5. Analyst Commentary
      • 23.4.11.6. Strategy Overview
        • 23.4.11.6.1. Marketing Strategy
        • 23.4.11.6.2. Product Strategy
        • 23.4.11.6.3. Channel Strategy
    • 23.4.12. Danaher Corporation
      • 23.4.12.1. Overview
      • 23.4.12.2. Product Portfolio
      • 23.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.12.4. Sales Footprint
      • 23.4.12.5. Analyst Commentary
      • 23.4.12.6. Strategy Overview
        • 23.4.12.6.1. Marketing Strategy
        • 23.4.12.6.2. Product Strategy
        • 23.4.12.6.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.